These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24072747)

  • 41. Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis.
    Zhang Y; Huang P; Liu X; Xiang Y; Zhang T; Wu Y; Xu J; Sun Z; Zhen W; Zhang L; Si Y; Liu Y
    J Pharmacol Sci; 2018 Jul; 137(3):305-312. PubMed ID: 30119963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polyphyllin I attenuates cognitive impairments and reduces AD-like pathology through CIP2A-PP2A signaling pathway in 3XTg-AD mice.
    Zhou Y; Yang D; Chen H; Zheng C; Jiang H; Liu X; Huang X; Ye S; Song S; Jiang N; Zhao Z; Ma S; Ma J; Huang K; Chen C; Fan X; Gong Y; Wang X; Fan J; Liu R; Shentu Y
    FASEB J; 2020 Dec; 34(12):16414-16431. PubMed ID: 33070372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CIP2A silencing alleviates doxorubicin resistance in MCF7/ADR cells through activating PP2A and autophagy.
    Zhu Z; Wei Z
    Clin Transl Oncol; 2021 Aug; 23(8):1542-1548. PubMed ID: 33948919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CIP2A regulates cancer metabolism and CREB phosphorylation in non-small cell lung cancer.
    Peng B; Lei N; Chai Y; Chan EK; Zhang JY
    Mol Biosyst; 2015 Jan; 11(1):105-14. PubMed ID: 25325377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CIP2A oncoprotein controls cell growth and autophagy through mTORC1 activation.
    Puustinen P; Rytter A; Mortensen M; Kohonen P; Moreira JM; Jäättelä M
    J Cell Biol; 2014 Mar; 204(5):713-27. PubMed ID: 24590173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.
    Laine A; Sihto H; Come C; Rosenfeldt MT; Zwolinska A; Niemelä M; Khanna A; Chan EK; Kähäri VM; Kellokumpu-Lehtinen PL; Sansom OJ; Evan GI; Junttila MR; Ryan KM; Marine JC; Joensuu H; Westermarck J
    Cancer Discov; 2013 Feb; 3(2):182-97. PubMed ID: 23306062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions.
    Jung HM; Patel RS; Phillips BL; Wang H; Cohen DM; Reinhold WC; Chang LJ; Yang LJ; Chan EK
    Mol Biol Cell; 2013 Jun; 24(11):1638-48, S1-7. PubMed ID: 23552692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer.
    Farrell AS; Allen-Petersen B; Daniel CJ; Wang X; Wang Z; Rodriguez S; Impey S; Oddo J; Vitek MP; Lopez C; Christensen DJ; Sheppard B; Sears RC
    Mol Cancer Res; 2014 Jun; 12(6):924-39. PubMed ID: 24667985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PP2A inhibition is a common event in colorectal cancer and its restoration using FTY720 shows promising therapeutic potential.
    Cristóbal I; Manso R; Rincón R; Caramés C; Senin C; Borrero A; Martínez-Useros J; Rodriguez M; Zazo S; Aguilera O; Madoz-Gúrpide J; Rojo F; García-Foncillas J
    Mol Cancer Ther; 2014 Apr; 13(4):938-47. PubMed ID: 24448818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism.
    Wang HW; Yang SH; Huang GD; Lin JK; Chen WS; Jiang JK; Lan YT; Lin CC; Hwang WL; Tzeng CH; Li AF; Yen CC; Teng HW
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):561-71. PubMed ID: 24493623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers.
    Khanna A; Pimanda JE
    Int J Cancer; 2016 Feb; 138(3):525-32. PubMed ID: 25628223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A.
    Chen KF; Yu HC; Liu CY; Chen HJ; Chen YC; Hou DR; Chen PJ; Cheng AL
    Mol Cancer Ther; 2011 May; 10(5):892-901. PubMed ID: 21393428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
    Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
    Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cucurbitacin B Induces the Lysosomal Degradation of EGFR and Suppresses the CIP2A/PP2A/Akt Signaling Axis in Gefitinib-Resistant Non-Small Cell Lung Cancer.
    Liu P; Xiang Y; Liu X; Zhang T; Yang R; Chen S; Xu L; Yu Q; Zhao H; Zhang L; Liu Y; Si Y
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30759826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2A.
    Fujiki H; Sueoka E; Watanabe T; Komori A; Suganuma M
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9425-9433. PubMed ID: 37097392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CIP2A influences survival in colon cancer and is critical for maintaining Myc expression.
    Wiegering A; Pfann C; Uthe FW; Otto C; Rycak L; Mäder U; Gasser M; Waaga-Gasser AM; Eilers M; Germer CT
    PLoS One; 2013; 8(10):e75292. PubMed ID: 24098375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. KIAA1524/CIP2A promotes cancer growth by coordinating the activities of MTORC1 and MYC.
    Puustinen P; Jäättelä M
    Autophagy; 2014 Jul; 10(7):1352-4. PubMed ID: 24905455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CIP2A and PP2A in human leptomeninges, arachnoid granulations and meningiomas.
    Johnson MD; Reeder JE; O'Connell M; Woodford M; Walter K
    J Clin Neurosci; 2014 Dec; 21(12):2228-32. PubMed ID: 25012485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein phosphatase 2A regulation of markers of extracellular matrix remodelling in hepatocellular carcinoma cells: functional consequences for tumour invasion.
    Ward MP; Spiers JP
    Br J Pharmacol; 2017 May; 174(10):1116-1130. PubMed ID: 28239848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CIP2A regulates cell proliferation via the AKT signaling pathway in human lung cancer.
    Lei N; Peng B; Zhang JY
    Oncol Rep; 2014 Oct; 32(4):1689-94. PubMed ID: 25109354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.